Biological mechanisms of neural stem cell differentiation and axon regeneration identified

Recent biological research has identified new mechanisms regulating neural regeneration and stem cell differentiation in both the brain and spinal cord.

In studies regarding the ventricular-subventricular zone (V-SVZ), researchers found that the enzyme monoacylglycerol lipase (Mgll) acts as a gatekeeper for neural stem and progenitor cell differentiation. In models of Alzheimer’s disease, the overexpression of Mgll in the hypothalamic arcuate nucleus was linked to inhibited neurogenesis and olfactory deficits. Deleting Mgll in specific neurons was shown to increase pro-differentiation transcription factors, potentially offering a strategy to restore neurogenic potency.

Separately, research into chronic spinal cord injury (SCI) examined the impact of sustained neuroinflammation. Using a colony-stimulating factor-1 receptor inhibitor to deplete microglia and macrophages in mice, researchers observed that while inflammatory depletion alone had limited effects, the subsequent repopulation of these cells was associated with increased axon densities within lesion sites. This suggests that the interaction between chronic inflammation and neuronal transcripts plays a significant role in axon regeneration following injury.